Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.920
+0.100 (3.55%)
At close: Mar 28, 2024, 4:00 PM
3.010
+0.090 (3.08%)
After-hours: Mar 28, 2024, 7:16 PM EDT

Oramed Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Revenue
1.342.72.72.712.72.452.460.6400
Upgrade
Revenue Growth (YoY)
-50.43%0%-0.26%0.26%10.37%-0.29%283.15%---
Upgrade
Cost of Revenue
00000.09-0.090.190.4900
Upgrade
Gross Profit
1.342.72.72.712.612.542.270.1500
Upgrade
Selling, General & Admin
8.1415.665.944.233.724.082.762.452.62.63
Upgrade
Research & Development
8.9727.6420.9910.2413.5211.9810.287.714.783.28
Upgrade
Operating Expenses
17.1143.326.9314.4717.2416.0613.0410.167.385.91
Upgrade
Operating Income
-15.77-40.6-24.22-11.76-14.63-13.53-10.77-10.01-7.38-5.91
Upgrade
Interest Expense / Income
2.0400.010.440.490.10.10.090.020.01
Upgrade
Other Expense / Income
-23.33-4.14-1.99-0.69-1.06-0.9-0.79-0.47-0.17-0.23
Upgrade
Pretax Income
5.53-36.46-22.24-11.51-14.06-12.73-10.08-9.63-7.23-5.69
Upgrade
Income Tax
00.1000.300.41.34-00
Upgrade
Net Income
5.53-36.56-22.24-11.51-14.36-12.73-10.48-10.96-7.23-5.7
Upgrade
Shares Outstanding (Basic)
4039282117151313119
Upgrade
Shares Outstanding (Diluted)
4139282117151313119
Upgrade
Shares Change
4.02%36.98%38.65%17.63%17.28%11.82%5.43%16.67%17.05%28.22%
Upgrade
EPS (Basic)
0.14-0.94-0.78-0.56-0.82-0.86-0.79-0.87-0.67-0.62
Upgrade
EPS (Diluted)
0.14-0.94-0.78-0.56-0.82-0.86-0.79-0.87-0.67-0.62
Upgrade
Free Cash Flow
-10.55-28.39-21.56-12.52-12.96-14.66-5.844.65-4.95-4.08
Upgrade
Free Cash Flow Per Share
-0.26-0.73-0.76-0.61-0.74-0.98-0.440.37-0.46-0.44
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%96.67%103.51%92.39%23.56%--
Upgrade
Operating Margin
-1176.79%-1501.96%-896.15%-433.84%-541.29%-552.35%-438.56%-1561.62%--
Upgrade
Profit Margin
412.31%-1352.61%-822.72%-424.76%-531.08%-519.68%-426.71%-1710.45%--
Upgrade
Free Cash Flow Margin
-787.24%-1050.31%-797.48%-462.07%-479.28%-598.69%-237.70%724.80%--
Upgrade
EBITDA
7.76-36.4-22.15-11.06-13.56-12.62-9.97-9.53-7.21-5.68
Upgrade
EBITDA Margin
578.96%-1346.76%-819.57%-408.12%-501.74%-515.23%-406.11%-1487.05%--
Upgrade
Depreciation & Amortization
0.20.060.080.010.010.010.01000.01
Upgrade
EBIT
7.56-36.46-22.23-11.07-13.57-12.62-9.98-9.54-7.22-5.68
Upgrade
EBIT Margin
564.33%-1348.91%-822.42%-408.38%-502.03%-515.48%-406.31%-1487.68%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).